Wolverine Trading, LLC Sangamo Therapeutics, Inc Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

22 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	BUY	$1.66 - $3.67 $9,130 - $20,185	5,500 Added 35.71%	20,900 $36,000
Q4 2022 Feb 14, 2023	SELL	$2.77 - $5.07 $8,864 - $16,224	-3,200 Reduced 17.2%	15,400 $48,000
Q3 2022 Nov 14, 2022	SELL	$4.27 - $6.39 $18,787 - $28,116	-4,400 Reduced 19.13%	18,600 $91,000
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.21 $2,296 - $4,347	700 Added 3.14%	23,000 $95,000
Q1 2022 May 16, 2022	SELL	$5.23 - $7.82 $46,547 - $69,598	-8,900 Reduced 28.53%	22,300 $132,000
Q4 2021 Feb 14, 2022	SELL	$7.29 - $10.97 $32,805 - $49,365	-4,500 Reduced 12.61%	31,200 $244,000
Q3 2021 Nov 12, 2021	SELL	$9.01 - $12.01 $100,912 - $134,512	-11,200 Reduced 23.88%	35,700 $326,000
Q2 2021 Aug 06, 2021	SELL	$10.17 - $12.64 $114,921 - $142,832	-11,300 Reduced 19.42%	46,900 $550,000
Q1 2021 May 14, 2021	SELL	$10.88 - $17.05 $628,864 - $985,490	-57,800 Reduced 49.83%	58,200 $679,000
Q4 2020 Feb 12, 2021	BUY	$9.23 - $18.18 $640,562 - $1.26 Million	69,400 Added 148.93%	116,000 $1.96 Million
Q3 2020 Nov 13, 2020	SELL	$9.38 - $12.48 $214,802 - $285,792	-22,900 Reduced 32.95%	46,600 $461,000
Q2 2020 Aug 13, 2020	BUY	$6.21 - $11.83 $19,872 - $37,856	3,200 Added 4.83%	69,500 $610,000
Q1 2020 May 11, 2020	BUY	$5.05 - $8.85 $124,735 - $218,595	24,700 Added 59.38%	66,300 $430,000
Q4 2019 Feb 12, 2020	BUY	$8.03 - $11.7 $61,830 - $90,090	7,700 Added 22.71%	41,600 $339,000
Q3 2019 Nov 14, 2019	SELL	$9.05 - $12.22 $435,305 - $587,782	-48,100 Reduced 58.66%	33,900 $312,000
Q2 2019 Aug 20, 2019	SELL	$8.75 - $13.03 $242,375 - $360,931	-27,700 Reduced 25.25%	82,000 $883,000
Q1 2019 May 15, 2019	SELL	$7.72 - $12.81 $579,000 - $960,750	-75,000 Reduced 40.61%	109,700 $1.05 Million
Q4 2018 Feb 14, 2019	SELL	$9.51 - $16.6 $144,552 - $252,320	-15,200 Reduced 7.6%	184,700 $2.01 Million
Q3 2018 Nov 14, 2018	BUY	$13.05 - $19.05 $726,885 - $1.06 Million	55,700 Added 38.63%	199,900 $3.39 Million
Q1 2018 May 15, 2018	BUY	$16.7 - $26.35 $584,500 - $922,250	35,000 Added 32.05%	144,200 $2.74 Million
Q4 2017 Feb 14, 2018	SELL	$11.6 - $17.35 $163,560 - $244,635	-14,100 Reduced 11.44%	109,200 $1.79 Million
Q3 2017 Nov 15, 2017	BUY	$8.4 - $15.0 $1.04 Million - $1.85 Million	123,300	123,300 $1.85 Million

Others Institutions Holding SGMO

# of Institutions

111

Shares Held

56.4M

Call Options Held

576K

Put Options Held

1.17M

Wasatch Advisors Inc Salt Lake City, UT

19.4M
Shares

$22 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

9.6M
Shares

$10.8 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.85M
Shares

$5.48 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$5.31 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.35M
Shares

$2.66 Million
0.0% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $177M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account